Financing, Equity Capital Markets
Madrigal Pharmaceuticals, Inc.
09/23
|
$499.9 Million
Âé¶¹´«Ã½ served as bookrunner for Madrigal Pharmaceuticals, Inc. on a confidentially marketed follow-on offering
Sub-Type
Confidentially Marketed Follow-On Offering
Sector
Sub-Sector
Biopharma